Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02ELG
|
||||
| Former ID |
DNC013680
|
||||
| Drug Name |
4-formylphenyl-O-beta-Dglucopyranoside
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528897] | ||
| Formula |
C13H16O7
|
||||
| Canonical SMILES |
C1=CC(=CC=C1C=O)OC2C(C(C(C(O2)CO)O)O)O
|
||||
| InChI |
1S/C13H16O7/c14-5-7-1-3-8(4-2-7)19-13-12(18)11(17)10(16)9(6-15)20-13/h1-5,9-13,15-18H,6H2/t9-,10-,11+,12-,13-/m1/s1
|
||||
| InChIKey |
OLZAGZCCJJBKNZ-UJPOAAIJSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Acetylcholinesterase | Target Info | Inhibitor | [528897] | |
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| References | |||||